在肝脏疾病诊断领域，FibroScan无创肝纤维化和脂肪肝变量化检测仪凭借其卓越的性能和广泛的临床验证，获得WHO 2024乙肝指南的权威推荐，成为肝纤维化无创诊断的金标准。这一国际背书不仅彰显了设备在全球肝病诊疗中的重要地位，更为医院管理者、采购 ...

PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could significantly improve patient diagnosis and care, as data presented at the American ...